More than 7300 individuals are on waiting lists for heart transplant in the United States during the course of a year, yet only about 3200 transplants are performed annually,1 with a waiting list mortality rate of 10% between 2015 and 2017.1 This unacceptably high waiting list mortality is due, in part, to a shortage of suitable donor organs. Because the need for donor hearts continues to exceed supply, the optimal distribution of available organs remains a challenge. Ideally, donor hearts would be allocated to patients who would benefit most from transplant, thereby ensuring maximal gains in survival and quality of life.
Sandhu AT, Woo YJ, Khush KK. Optimizing the Use of Heart Transplant in the United States. JAMA. 2019;322(18):1772–1774. doi:10.1001/jama.2019.16002
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: